Promise Tracker
0 delivered, 0 close, 1 missed.
View Promises →Dabur's Q1 FY26 consolidated revenue grew only 1.7% YoY due to unseasonal rains impacting the seasonal portfolio (beverages, glucose).
✓ Verified against BSE filing
Dabur's Q1 FY26 consolidated revenue grew only 1.7% YoY due to unseasonal rains impacting the seasonal portfolio (beverages, glucose). Ex-seasonal, growth was 7%. Domestic revenue grew 4.3% ex-seasonal, while international business delivered 13.7% constant currency growth. Operating profit and PAT grew ahead of revenue, supported by price increases and cost savings. Management expects high single-digit full-year growth, with Q2 likely double-digit due to a low base, though beverages remain under pressure. Key risks include sustained inflation in edible oils (projected ~8%) and competitive intensity requiring higher trade spends. The company is focusing on core brands, premiumization, and M&A in wellness to drive long-term growth.
डाबर की पहली तिमाही (अप्रैल-जून 2025) की कुल बिक्री में सिर्फ 1.7% की बढ़ोतरी हुई। इसकी वजह बेमौसम बारिश है, जिससे ड्रिंक्स और ग्लूकोज जैसे मौसमी उत्पादों की बिक्री प्रभावित हुई। अगर मौसमी उत्पादों को छोड़ दें, तो बिक्री 7% बढ़ी। भारत में बिक्री 4.3% और विदेशों में 13.7% बढ़ी। कंपनी का मुनाफा बिक्री से ज्यादा बढ़ा, क्योंकि उसने कीमतें बढ़ाईं और लागत बचाई। कंपनी को उम्मीद है कि पूरे साल बिक्री 7-9% बढ़ेगी और अगली तिमाही में 10% से ज्यादा बढ़ सकती है। हालांकि, खाने के तेल की कीमतें 8% तक बढ़ सकती हैं और प्रतिस्पर्धा बढ़ने से खर्च भी बढ़ेगा। कंपनी अपने मजबूत ब्रांडों, महंगे उत्पादों और सेहत से जुड़े कारोबार पर ध्यान दे रही है।
0 delivered, 0 close, 1 missed.
View Promises →Sustained inflation in edible oils
View Risks →Full transcript text is available on this route.
Read Transcript →Volume growth for the ex-seasonal portfolio, indicating underlying demand recovery.
Gained market share in oral care, driven by herbal segment tailwinds and strong Red franchise growth.
Highest ever market share in hair oils, outperforming category growth.
Robust double-digit growth across key geographies, with MENA up 10%, Sub-Saharan Africa up 20%, UK/EU up 40%.
Due to a favorable base (5.5% decline last year), Q2 is expected to deliver double-digit growth, though beverages may be low single-digit.
Management targets a significant improvement in operating margin for the full year, supported by premiumization and cost initiatives.
Company is scouting for M&A targets in wellness foods and health, with a path to profitability equitative to base margins.
Management expects high single-digit consolidated revenue growth for FY26, with Q2 likely double-digit due to a low base.
Dabur aims to achieve sustainable double-digit CAGR in both top line and bottom line by financial year 2028.
Management plans to exit tea, baby diapers, and Vita (MFD) categories, which are margin-dilutive and contribute less than 1% of revenue.
Management flagged ~8% inflation in edible oils, which could pressure gross margins if not fully mitigated by price hikes and savings.
Increased competition from Colgate and in hair oils has led to higher BTL spending, netting off from top line and pressuring gross margins.
Unseasonal rains and a short summer severely impacted beverages and glucose, leading to a ~30% decline in glucose and low single-digit beverage growth.
Analysts raised concerns about reduced disclosures in the investor presentation, which may hinder detailed performance tracking.
Beverage segment faces heightened competition from Campa Cola and others, with management expecting only low to mid-single-digit growth in FY26.
Inflation and inability to fully pass through price increases led to 240bps gross margin contraction. Upcoming recycled plastic regulations could further pressure margins.
Healthcare sales remain at FY21 levels, and beverages face structural challenges. Recovery is expected to be gradual, with no quick turnaround.
Mentioned in Q2 FY25, Q4 FY25
Beverage segment faces heightened competition from Campa Cola and others, with management expecting only low to mid-single-digit growth in FY26.
Mentioned in Q1 FY25, Q2 FY25
Currency depreciation in Egypt and Turkey caused a translation loss of INR 181 crore in H1, impacting reported international profitability.
Mentioned in Q2 FY25, Q3 FY25
Management expects sequential improvement and mid-single-digit value growth in Q4, driven by price increases and volume recovery.
Mentioned in Q1 FY25, Q2 FY25
Management expects the home care portfolio to grow from INR 700 crore to INR 1,000 crore in a two- to three-year time frame.
Mentioned in Q2 FY25, Q3 FY25
Urban consumption growth has moderated to ~5%, impacting categories like juices and healthcare supplements.
Management expects high single-digit consolidated revenue growth for FY26, with Q2 likely double-digit due to a low base.
Management flagged ~8% inflation in edible oils, which could pressure gross margins if not fully mitigated by price hikes and savings.
View Risks →